Galena Biopharma In The News
- Galena Biopharma Receives Notice of Allowance of Improvement Patent for NeuVax(TM) (nelipepimut-S) in Japan
- Galena Biopharma Announces Notice of Allowance of U.S. Patent Application for NeuVax(TM) (nelipepimut-S) Combination
- Galena Biopharma Announces Release of Special Committee Report and Hosting of a Conference Call to Provide a Corporate Update
- Galena Biopharma Doses First Patient in GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial
Galena is committed to ensuring eligible patients have access to our products. Learn more at GalenaPatientServices.com.